Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GED-301
GED-301
Price Hikes Insulate Celgene From a Failure
Motley Fool
Wed, 10/25/17 - 10:41 pm
Celgene
drug pricing
GED-301
Crohn's Disease
How Big of a Deal Is Celgene's Flop?
Motley Fool
Sat, 10/21/17 - 10:23 am
Celgene
GED-301
Crohn’s disease
ozanimod
Otezla
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Safety Worries Over Celgene's Experimental Crohn's Drug Overblown
TheStreet.com
Wed, 09/17/14 - 08:41 am
Celgene
Crohn's Disease
GED-301